Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 2321.31 Billion JPY | 1.76% |
| 2023 | 2783.4 Billion JPY | 13.05% |
| 2022 | 2462.16 Billion JPY | 11.74% |
| 2021 | 2203.5 Billion JPY | 0.09% |
| 2020 | 2201.42 Billion JPY | 53.14% |
| 2019 | 1437.53 Billion JPY | 12.78% |
| 2018 | 1274.61 Billion JPY | 8.63% |
| 2017 | 1173.29 Billion JPY | -7.76% |
| 2016 | 1271.97 Billion JPY | 1.2% |
| 2015 | 1256.83 Billion JPY | 4.61% |
| 2014 | 1201.42 Billion JPY | 8.27% |
| 2013 | 1109.63 Billion JPY | 3.15% |
| 2012 | 1075.73 Billion JPY | -2.37% |
| 2011 | 1101.8 Billion JPY | -6.7% |
| 2010 | 1180.9 Billion JPY | -5.44% |
| 2009 | 1248.79 Billion JPY | 13.92% |
| 2008 | 1096.17 Billion JPY | 6.89% |
| 2007 | 1025.5 Billion JPY | 10.26% |
| 2006 | 930.1 Billion JPY | 10.23% |
| 2005 | 843.78 Billion JPY | 3.27% |
| 2004 | 817.03 Billion JPY | 9.56% |
| 2003 | 745.73 Billion JPY | 11.77% |
| 2002 | 667.2 Billion JPY | 15.14% |
| 2001 | 579.46 Billion JPY | 18.07% |
| 2000 | 490.79 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 737.5 Billion JPY | 36.66% |
| 2024 Q3 | 731.7 Billion JPY | 4.6% |
| 2024 FY | 2321.31 Billion JPY | -16.6% |
| 2024 Q4 | 668.36 Billion JPY | -8.66% |
| 2024 Q2 | 699.5 Billion JPY | -2.87% |
| 2023 Q1 | 679.58 Billion JPY | 20.3% |
| 2023 Q3 | 760.57 Billion JPY | 9.14% |
| 2023 FY | 2783.4 Billion JPY | 13.05% |
| 2023 Q4 | 646.38 Billion JPY | -15.01% |
| 2023 Q2 | 696.86 Billion JPY | 2.54% |
| 2022 FY | 2462.16 Billion JPY | 11.74% |
| 2022 Q3 | 619.89 Billion JPY | 8.94% |
| 2022 Q1 | 708.33 Billion JPY | 37.06% |
| 2022 Q4 | 564.9 Billion JPY | -8.87% |
| 2022 Q2 | 569.02 Billion JPY | -19.67% |
| 2021 Q2 | 539.29 Billion JPY | -4.34% |
| 2021 Q3 | 583.61 Billion JPY | 8.22% |
| 2021 Q4 | 516.82 Billion JPY | -11.44% |
| 2021 FY | 2203.5 Billion JPY | 0.09% |
| 2021 Q1 | 563.77 Billion JPY | 7.69% |
| 2020 Q1 | 548.52 Billion JPY | 28.35% |
| 2020 Q3 | 579.74 Billion JPY | 7.49% |
| 2020 Q4 | 523.52 Billion JPY | -9.7% |
| 2020 FY | 2201.42 Billion JPY | 53.14% |
| 2020 Q2 | 539.33 Billion JPY | -1.68% |
| 2019 Q3 | 360.88 Billion JPY | 12.77% |
| 2019 Q4 | 427.37 Billion JPY | 18.42% |
| 2019 FY | 1437.53 Billion JPY | 12.78% |
| 2019 Q2 | 320.02 Billion JPY | -2.8% |
| 2019 Q1 | 329.24 Billion JPY | 13.5% |
| 2018 Q2 | 311.3 Billion JPY | -4.91% |
| 2018 FY | 1274.61 Billion JPY | 8.63% |
| 2018 Q4 | 290.07 Billion JPY | -16.13% |
| 2018 Q3 | 345.86 Billion JPY | 11.1% |
| 2018 Q1 | 327.37 Billion JPY | 16.17% |
| 2017 Q1 | 298.61 Billion JPY | 6.21% |
| 2017 FY | 1173.29 Billion JPY | -7.76% |
| 2017 Q4 | 281.79 Billion JPY | -11.26% |
| 2017 Q3 | 317.55 Billion JPY | 15.33% |
| 2017 Q2 | 275.33 Billion JPY | -7.8% |
| 2016 Q1 | 325.17 Billion JPY | 7.23% |
| 2016 FY | 1271.97 Billion JPY | 1.2% |
| 2016 Q3 | 344.18 Billion JPY | 7.07% |
| 2016 Q2 | 321.46 Billion JPY | -1.14% |
| 2016 Q4 | 281.15 Billion JPY | -18.31% |
| 2015 Q3 | 349.21 Billion JPY | 12.19% |
| 2015 FY | 1256.83 Billion JPY | 4.61% |
| 2015 Q4 | 303.25 Billion JPY | -13.16% |
| 2015 Q2 | 311.25 Billion JPY | 6.19% |
| 2015 Q1 | 293.1 Billion JPY | 7.03% |
| 2014 Q2 | 297.6 Billion JPY | 0.81% |
| 2014 Q3 | 327.28 Billion JPY | 9.97% |
| 2014 Q4 | 273.86 Billion JPY | -16.32% |
| 2014 FY | 1201.42 Billion JPY | 8.27% |
| 2014 Q1 | 295.21 Billion JPY | 14.83% |
| 2013 Q4 | 257.08 Billion JPY | -8.73% |
| 2013 FY | 1109.63 Billion JPY | 3.15% |
| 2013 Q1 | 294.97 Billion JPY | 16.52% |
| 2013 Q2 | 275.89 Billion JPY | -6.47% |
| 2013 Q3 | 281.67 Billion JPY | 2.09% |
| 2012 Q1 | 278.31 Billion JPY | 8.99% |
| 2012 Q4 | 253.14 Billion JPY | -9.48% |
| 2012 Q3 | 279.65 Billion JPY | 5.68% |
| 2012 Q2 | 264.61 Billion JPY | -4.92% |
| 2012 FY | 1075.73 Billion JPY | -2.37% |
| 2011 Q4 | 255.36 Billion JPY | -9.76% |
| 2011 Q1 | 281.59 Billion JPY | 5.24% |
| 2011 Q2 | 281.84 Billion JPY | 0.09% |
| 2011 Q3 | 282.99 Billion JPY | 0.41% |
| 2011 FY | 1101.8 Billion JPY | -6.7% |
| 2010 FY | 1180.9 Billion JPY | -5.44% |
| 2010 Q3 | 298.24 Billion JPY | -2.99% |
| 2010 Q2 | 307.43 Billion JPY | -0.07% |
| 2010 Q4 | 267.58 Billion JPY | -10.28% |
| 2010 Q1 | 307.64 Billion JPY | 15.09% |
| 2009 Q4 | 267.3 Billion JPY | -17.77% |
| 2009 FY | 1248.79 Billion JPY | 13.92% |
| 2009 Q2 | 338.17 Billion JPY | 0.0% |
| 2009 Q3 | 325.05 Billion JPY | -3.88% |
| 2008 FY | 1096.17 Billion JPY | 6.89% |
| 2007 FY | 1025.5 Billion JPY | 10.26% |
| 2006 FY | 930.1 Billion JPY | 10.23% |
| 2005 FY | 843.78 Billion JPY | 3.27% |
| 2004 FY | 817.03 Billion JPY | 9.56% |
| 2003 FY | 745.73 Billion JPY | 11.77% |
| 2002 FY | 667.2 Billion JPY | 15.14% |
| 2001 FY | 579.46 Billion JPY | 18.07% |
| 2000 FY | 490.79 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 820.56 Million USD | -282791.788% |
| Bausch Health Companies Inc. | 6.19 Billion USD | -37352.581% |
| Catalent, Inc. | 953 Million USD | -243479.328% |
| Emergent BioSolutions Inc. | 343.9 Million USD | -674895.929% |
| Elanco Animal Health Incorporated | 2.48 Billion USD | -93275.342% |
| Perrigo Company plc | 1.68 Billion USD | -138040.383% |
| Teva Pharmaceutical Industries Limited | 7.64 Billion USD | -30259.809% |
| Zoetis Inc. | 5.83 Billion USD | -39689.356% |